[使用Arrow-Trerotola装置对血栓形成的移植动静脉内瘘患者进行经皮机械血栓切除术]
[Percutaneous mechanical thrombectomy with arrow-trerotola device inpatients with thrombosed graft fistula].
作者信息
Firat Ali, Aytekin Cüneyt, Boyvat Fatih, Emiroğlu Remzi, Haberal Mehmet
机构信息
Başkent Universitesi Tip Fakültesi, Radyoloji Anabilim Dali, Ankara.
出版信息
Tani Girisim Radyol. 2003 Sep;9(3):371-6.
PURPOSE
To assess the safety and efficacy of the Arrow-Trerotola percutaneous thrombectomy device in the treatment of thrombosed hemodialysis access grafts in dialysis patients.
MATERIALS AND METHODS
Ten patients with graft fistula occlusion underwent mechanical thrombectomy with Arrow-Trerotola percutaneous thrombectomy device. Thirteen thrombectomy procedures were performed in ten patients. Technical success, complications, primary and secondary patency rates were noted.
RESULTS
The technical success rate was 84% (11 of 13 procedures). There were no major complications. The mean follow-up period was 8.5 months. The graft fistula are still functional in seven patients. In 3 of 7 patients, additional procedures were needed for patency. The 3-month primary and secondary patency rates were 66% and 77% respectively.
CONCLUSION
Percutaneous mechanical thrombectomy with the Arrow-Trerotola device is an effective method for the treatment of the thrombosed hemodialysis grafts.
目的
评估Arrow-Trerotola经皮血栓切除术装置治疗透析患者血栓形成的血液透析通路移植物的安全性和有效性。
材料与方法
10例移植物内瘘闭塞患者接受了使用Arrow-Trerotola经皮血栓切除术装置的机械血栓切除术。10例患者共进行了13次血栓切除手术。记录技术成功率、并发症、一期和二期通畅率。
结果
技术成功率为84%（13例手术中的11例）。无重大并发症。平均随访期为8.5个月。7例患者的移植物内瘘仍保持功能。7例患者中有3例需要额外的手术来维持通畅。3个月时的一期和二期通畅率分别为66%和77%。
结论
使用Arrow-Trerotola装置进行经皮机械血栓切除术是治疗血栓形成的血液透析移植物的有效方法。
Zotero 插件